Scinai Immunotherapeutics Ltd.
SCNI
$1.13
-$0.14-11.02%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2023 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.00% | -49.64% | -23.45% | -23.45% | -15.24% |
| Total Receivables | 0.00% | -35.94% | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 0.00% | 198.73% | -68.86% | -68.86% | 65.22% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | 8.40% | 14.75% | 14.75% | -3.17% |
| Total Current Assets | 0.00% | -37.01% | -18.85% | -18.85% | -13.62% |
|
|
|||||
| Total Current Assets | 0.00% | -37.01% | -18.85% | -18.85% | -13.62% |
| Net Property, Plant & Equipment | 0.00% | -6.54% | 1.31% | 1.31% | -2.12% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 0.00% | -11.96% | -5.97% | -5.97% | -6.61% |
|
|
|||||
| Total Accounts Payable | 0.00% | 75.27% | -2.01% | -2.01% | -16.13% |
| Total Accrued Expenses | -- | -- | 39.18% | 39.18% | -27.64% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.00% | 17.22% | 3.66% | 3.66% | -3.05% |
| Total Finance Division Other Current Liabilities | 0.00% | 328.44% | -- | -- | -- |
| Total Other Current Liabilities | 0.00% | 328.44% | -- | -- | -- |
| Total Current Liabilities | 0.00% | 17.39% | 15.73% | 15.73% | -18.54% |
|
|
|||||
| Total Current Liabilities | 0.00% | 17.39% | 15.73% | 15.73% | -18.54% |
| Long-Term Debt | 0.00% | 12.69% | 4.12% | 4.12% | -20.14% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 0.00% | 11.70% | -3.16% | -3.16% | -11.22% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | 0.00% | -69.13% | -69.13% | -65.52% |
| Total Liabilities | 0.00% | 14.72% | 3.61% | 3.61% | -21.23% |
|
|
|||||
| Common Stock & APIC | 0.00% | 1.63% | 0.38% | 0.38% | 1.12% |
| Retained Earnings | 0.00% | -3.52% | -1.94% | -1.94% | 2.52% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | 0.00% | -48.71% | -69.73% | -69.73% | 62.15% |
|
|
|||||
| Preferred Stock Redeemable | 0.00% | 0.00% | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | -- | -- | -- |
|
|
|||||
| Total Common Equity | 0.00% | -48.71% | -69.73% | -69.73% | 62.15% |
| Total Preferred Equity | 0.00% | 0.00% | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 0.00% | -21.24% | -69.73% | -69.73% | 62.15% |
|
|
|||||